A genetic modifier of venous thrombosis in zebrafish reveals a functional role for fibrinogen A?E in early hemostasis.
Ontology highlight
ABSTRACT: Plasma fibrinogen molecules comprise 2 copies of A?, B?, and ? chains folded into a hexameric protein. A minor fibrinogen isoform with an extended A? chain (A?E) is more abundant in newborn human blood than in adults. Larval zebrafish produce predominantly A?E-containing fibrinogen, but its functional significance is unclear. In 3-day-old zebrafish, when hemostasis is reliant on fibrinogen and erythrocyte-rich clotting but is largely thrombocyte-independent, we measured the time to occlusion (TTO) in a laser-induced venous thrombosis assay in 3 zebrafish strains (AB, TU, and AB × TL hybrids). AB larvae showed delayed TTO compared with the TU and AB × TL strains. Mating AB with TU or TL produced larvae with a TU-like TTO. In contrast to TU, AB larvae failed to produce fibrinogen A?E, due to a mutation in the A?E-specific coding region of fibrinogen ?-chain gene (fga). We investigated whether the lack of A?E explained the delayed AB TTO. Transgenic expression of A?E, but not A?, shortened the AB TTO to that of TU. A?E rescued venous occlusion in fibrinogen mutants or larvae with morpholino-targeted fibrinogen ?-chain messenger RNA, but A? was less effective. In 5-day-old larvae, circulating thrombocytes contribute to hemostasis, as visualized in Tg(itga2b:EGFP) transgenics. Laser-induced venous thrombocyte adhesion and aggregation is reduced in fibrinogen mutants, but transgenic expression of A? or A?E restored similar thrombocyte accumulation at the injury site. Our data demonstrate a genetic modifier of venous thrombosis and a role for fibrinogen A?E in early developmental blood coagulation, and suggest a link between differentially expressed fibrinogen isoforms and the cell types available for clotting.
SUBMITTER: Freire C
PROVIDER: S-EPMC7656923 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA